STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALHC
  4. [Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Alignment Healthcare (ALHC) legal chief sells stock under 10b5-1 plan

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Alignment Healthcare, Inc. reported that Chief Legal and Admin. Officer Christopher J. Joyce sold 18,013 shares of common stock in an open-market transaction. The weighted-average sale price was $17.7923 per share, within a range of $17.57 to $17.99. Following this sale, he directly holds 305,451 shares. The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on 09/08/2025.

Positive

  • None.

Negative

  • None.
Insider JOYCE CHRISTOPHER J
Role Chief Legal and Admin. Officer
Sold 18,013 shs ($320K)
Type Security Shares Price Value
Sale Common Stock 18,013 $17.7923 $320K
Holdings After Transaction: Common Stock — 305,451 shares (Direct)
Footnotes (1)
  1. Date of adoption of Rule 10b5-1 plan: 09/08/2025 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.57 to $17.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Shares sold 18,013 shares Open-market sale of common stock
Weighted-average sale price $17.7923 per share Price for 18,013 shares sold
Sale price range $17.57–$17.99 per share Range of individual trade prices
Shares held after transaction 305,451 shares Direct ownership after sale
Rule 10b5-1 plan adoption date 09/08/2025 Pre-arranged trading plan for transactions
Transaction date 2026-04-01 Date of reported open-market sale
Rule 10b5-1 plan regulatory
"The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on 09/08/2025."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
open-market sale financial
"sold 18,013 shares of common stock in an open-market transaction."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
common stock financial
"sold 18,013 shares of common stock in an open-market transaction."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"What insider transaction did Alignment Healthcare (ALHC) disclose on this Form 4?"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JOYCE CHRISTOPHER J
(Last)(First)(Middle)
1100 W. TOWN & COUNTRY RD.
SUITE 1600
(Street)
ORANGE CALIFORNIA 92868
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal and Admin. Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/01/2026S(1)18,013D$17.7923(2)305,451D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Date of adoption of Rule 10b5-1 plan: 09/08/2025
2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.57 to $17.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Remarks:
/s/ Christopher J. Joyce04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Alignment Healthcare (ALHC) disclose on this Form 4?

Alignment Healthcare disclosed that Chief Legal and Admin. Officer Christopher J. Joyce sold 18,013 common shares. The sale was an open-market transaction under a Rule 10b5-1 trading plan, giving investors transparency into his recent equity activity and remaining holdings.

At what prices did ALHC’s Christopher Joyce sell his Alignment Healthcare shares?

The reported price is a weighted-average of $17.7923 per share for 18,013 shares. According to the disclosure, individual trades occurred between $17.57 and $17.99, reflecting multiple transactions executed within that intraday price range.

How many Alignment Healthcare (ALHC) shares does Christopher Joyce hold after the sale?

After selling 18,013 shares, Christopher J. Joyce directly holds 305,451 Alignment Healthcare common shares. This post-transaction figure shows that he retains a substantial equity stake in the company despite the disclosed open-market sale.

Was the ALHC insider sale by Christopher Joyce made under a Rule 10b5-1 plan?

Yes. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on 09/08/2025. Such pre-arranged plans are designed to systematize trades and reduce the significance of trade timing signals for outside investors.

Who is the insider involved in this Alignment Healthcare (ALHC) Form 4 filing?

The insider is Christopher J. Joyce, Alignment Healthcare’s Chief Legal and Admin. Officer. As a company officer, his open-market equity transactions must be reported, providing visibility into his trading and ongoing ownership position in Alignment Healthcare stock.